Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has entered into agreements to acquire equity shares (up to 26.09%) of Agatsa Software, which is an early-stage digital diagnostic devices company and to acquire equity shares (27.39%) of Remidio Innovative Solutions, which provides innovative products enabling early detection of eye diseases.

The company has entered into agreements to acquire minority stake in Agatsa Software and Remidio Innovative Solutions which are non-material investments by the Company in the allied areas.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.